Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (131-140 of 377) with videos related to

Pageof 38
Sort By:
Arthritis and Rheumatism|June 3, 2008
Mycobacterium kansasii tenosynovitis in a rheumatoid arthritis patient with long-term therapeutic immunosuppressionHanns-Martin Lorenz, Alexander H Dalpke, Axel Deboben, et al.
European Journal of Haematology|March 18, 2014
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experienceAleksandar Radujkovic, Sascha Dietrich, Tilmann Bochtler, et al.
Stem Cells (Dayton, Ohio)|July 7, 2007
Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitorsWolfgang Wagner, Christoph Roderburg, Frederik Wein, et al.
Annals of Hematology|March 18, 2018
The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experienceSarah Rohlfing, Sascha Dietrich, Mathias Witzens-Harig, et al.
Stem Cells (Dayton, Ohio)|January 6, 2007
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cellsMathias Witzens-Harig, Conny Heilmann, Manfred Hensel, et al.
Journal of Cellular and Molecular Medicine|September 17, 2009
Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk groupChristoph E Heilig, Harald Löffler, Ulrich Mahlknecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2009
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantationPatrick Wuchter, Dan Ran, Thomas Bruckner, et al.
European Journal of Haematology|February 18, 2014
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemiaAleksandar Radujkovic, Peter Dreger, Ute Hegenbart, et al.
Blood|August 30, 2002
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myelomaKai Neben, Joannis Mytilineos, Thomas M Moehler, et al.
Cytotherapy|November 17, 2010
Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixaforIsabel Taubert, Rainer Saffrich, Abraham Zepeda-Moreno, et al.
Pageof 38

Showing results (131-140 of 377) with videos related to

Sort By:
Pageof 38
Arthritis and Rheumatism|June 3, 2008
Mycobacterium kansasii tenosynovitis in a rheumatoid arthritis patient with long-term therapeutic immunosuppressionHanns-Martin Lorenz, Alexander H Dalpke, Axel Deboben, et al.
European Journal of Haematology|March 18, 2014
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experienceAleksandar Radujkovic, Sascha Dietrich, Tilmann Bochtler, et al.
Stem Cells (Dayton, Ohio)|July 7, 2007
Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitorsWolfgang Wagner, Christoph Roderburg, Frederik Wein, et al.
Annals of Hematology|March 18, 2018
The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experienceSarah Rohlfing, Sascha Dietrich, Mathias Witzens-Harig, et al.
Stem Cells (Dayton, Ohio)|January 6, 2007
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cellsMathias Witzens-Harig, Conny Heilmann, Manfred Hensel, et al.
Journal of Cellular and Molecular Medicine|September 17, 2009
Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk groupChristoph E Heilig, Harald Löffler, Ulrich Mahlknecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2009
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantationPatrick Wuchter, Dan Ran, Thomas Bruckner, et al.
European Journal of Haematology|February 18, 2014
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemiaAleksandar Radujkovic, Peter Dreger, Ute Hegenbart, et al.
Blood|August 30, 2002
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myelomaKai Neben, Joannis Mytilineos, Thomas M Moehler, et al.
Cytotherapy|November 17, 2010
Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixaforIsabel Taubert, Rainer Saffrich, Abraham Zepeda-Moreno, et al.
Pageof 38